E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 2.4 EUR -22.88% Market Closed
Market Cap: 229.4m EUR

Gross Margin
Euroapi SAS

13.7%
Current
16%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
13.7%
=
Gross Profit
121m
/
Revenue
882.8m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
FR
Euroapi SAS
PAR:EAPI
228m EUR
14%
US
Eli Lilly and Co
NYSE:LLY
985.4B USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
506.1B USD
68%
CH
Roche Holding AG
SIX:ROG
252.5B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
210.2B GBP
82%
CH
Novartis AG
SIX:NOVN
207.2B CHF
76%
US
Merck & Co Inc
NYSE:MRK
246.7B USD
79%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
82%
IE
Endo International PLC
LSE:0Y5F
209B USD
68%
US
Pfizer Inc
NYSE:PFE
142.4B USD
75%
No Stocks Found

Euroapi SAS
Glance View

Market Cap
228m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
7.59 EUR
Undervaluation 68%
Intrinsic Value
Price
E
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
13.7%
=
Gross Profit
121m
/
Revenue
882.8m
What is the Gross Margin of Euroapi SAS?

Based on Euroapi SAS's most recent financial statements, the company has Gross Margin of 13.7%.

Back to Top